Published in Allergy on April 01, 1993
Controlled exposure to mite allergen for a dose-finding of dimethindene maleate (DMM). Agents Actions (1994) 0.75
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics (1995) 2.87
Symptoms of bronchial hyperreactivity and asthma in relation to environmental factors. Arch Dis Child (1988) 2.47
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J (2004) 2.36
Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol (1993) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun (1979) 2.08
A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics (1999) 2.00
Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy (1999) 1.86
Interaction of E. coli strains with human serum: lack of relationship to K1 antigen. J Pediatr (1976) 1.83
Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy (2003) 1.79
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
Soy versus cow's milk in infants with a biparental history of atopic disease: development of atopic disease and immunoglobulins from birth to 4 years of age. Clin Allergy (1979) 1.70
A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy (2011) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy (2009) 1.61
Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol (1997) 1.60
Cord blood levels of immunoglobulin G subclass antibodies to food and inhalant allergens in relation to maternal atopy and the development of atopic disease during the first 8 years of life. Clin Exp Allergy (2000) 1.58
Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy (2009) 1.58
Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J (2000) 1.57
Atopic disease in seven-year-old children. Incidence in relation to family history. Acta Paediatr Scand (1977) 1.57
Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy (1998) 1.50
Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria. Infect Immun (1978) 1.50
Thymus size and head circumference at birth and the development of allergic diseases. Clin Exp Allergy (2001) 1.48
Predictive value of high IgE levels in children. Acta Paediatr Scand (1976) 1.47
Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J (2001) 1.46
Immune responses to birch in young children during their first 7 years of life. Clin Exp Allergy (2002) 1.43
Local immunotherapy is not documented for clinical use. Allergy (1994) 1.43
Fatty acid composition in colostrum and mature milk from non-atopic and atopic mothers during the first 6 months of lactation. Acta Paediatr (1998) 1.42
Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 1.41
Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy (2000) 1.35
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol (2009) 1.30
The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers. Pediatrics (1979) 1.30
Allergens in school dust. I. The amount of the major cat (Fel d I) and dog (Can f I) allergens in dust from Swedish schools is high enough to probably cause perennial symptoms in most children with asthma who are sensitized to cat and dog. J Allergy Clin Immunol (1993) 1.29
A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch Pediatr Adolesc Med (1998) 1.29
Site-specific substituted cobalt(II) horse liver alcohol dehydrogenases. Preparation and characterization in solution, crystalline and immobilized state. Eur J Biochem (1979) 1.28
Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy (1995) 1.26
Collecting and banking human milk: to heat or not to heat? Br Med J (1980) 1.25
Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B. Infect Immun (1976) 1.25
Effect of parental smoking on IgE levels in children. Lancet (1981) 1.23
Interaction of Escherichia coli with different fimbriae and polymorphonuclear leukocytes. Infect Immun (1982) 1.23
Lack of association between pertussis vaccination and symptoms of asthma and allergy. JAMA (1996) 1.21
Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy (2005) 1.19
Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr (1978) 1.19
Pustulosis palmoplantaris and its relation to chronic recurrent multifocal osteomyelitis. Dermatologica (1979) 1.17
Increased IgE antibody responses in rats exposed to tobacco smoke. J Allergy Clin Immunol (1985) 1.16
Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res (2000) 1.15
Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health (2001) 1.14
Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child (1997) 1.14
An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol (2000) 1.13
The precision of the conjunctival provocation test. Allergy (1984) 1.13
Cord blood IgE determination for allergy prediction--a follow-up to seven years of age in 1,651 children. Ann Allergy (1984) 1.13
The prevalence of allergy and IgE antibodies to inhalant allergens in Swedish school children. Acta Paediatr Scand (1987) 1.12
Nasal metachromatic cells in infancy in relation to the appearance of atopic disease during the first 6 years of life. Allergy (1997) 1.12
Risk factors for respiratory symptoms and atopic sensitisation in the Baltic area. Arch Dis Child (1995) 1.11
Neutropenia induced by systemic infusion of lactoferrin. J Lab Clin Med (1982) 1.11
Distinct pattern of commensal gut microbiota in toddlers with eczema. Int Arch Allergy Immunol (2006) 1.10
Atopic sensitization and respiratory symptoms among Polish and Swedish school children. Clin Exp Allergy (1994) 1.08
Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem (1996) 1.06
International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergens. Eur Respir J (2008) 1.05
IgE screening in 1701 newborn infants and the development of atopic disease during infancy. Arch Dis Child (1982) 1.05
Children with asthma: how do they get along at school? Acta Paediatr Scand (1985) 1.05
IgE and atopic allergy in newborns and infants with a family history of atopic disease. Acta Paediatr Scand (1976) 1.04
Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy (2002) 1.04
Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol (1993) 1.03
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients. Gynecol Oncol (2000) 1.02
High body mass index, asthma and allergy in Swedish schoolchildren participating in the International Study of Asthma and Allergies in Childhood: Phase II. Acta Paediatr (2003) 1.01
Bronchial asthma and acid reflux into the distal and proximal oesophagus. Arch Dis Child (1990) 1.01
Cat (Fel d I), dog (Can f I), and cockroach allergens in homes of asthmatic children from three climatic zones in Sweden. Allergy (1994) 1.01
Longterm treatment with brompheniramine and phenylpropanolamine in recurrent otitis media--a double-blind study. J Otolaryngol (1978) 1.01
Limiting factors in bacterial phagocytosis by human polymorphonuclear leukocytes. Acta Pathol Microbiol Scand C (1977) 1.01
Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9. Cancer (2000) 1.01
Intestinal permeability in healthy and allergic children before and after sodium-cromoglycate treatment assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy (1984) 1.01
Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. Biochim Biophys Acta (1977) 1.00
Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res (1977) 1.00
A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux. Eur Respir J (1992) 1.00
Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop. Tumour Biol (2000) 1.00
Family therapy in the treatment of severe childhood asthma. J Psychosom Res (1986) 0.99
Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Tumour Biol (1998) 0.99
Antigenic variability of different strains of Aspergillus fumigatus. Int Arch Allergy Appl Immunol (1984) 0.99
A double-blind comparison between a new multidose powder inhaler (Turbuhaler) and metered dose inhaler in children with asthma. Allergy (1989) 0.99
Hypoallergenicity of an extensively hydrolyzed whey formula. Pediatr Allergy Immunol (2001) 0.98
Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect Immun (1991) 0.98
Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatr Res (2000) 0.98
Mite fauna in the home and sensitivity to house-dust and storage mites. Allergy (1999) 0.98
Adverse reactions to food and food allergy in young children in Iceland and Sweden. Scand J Prim Health Care (1999) 0.97
Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol (1994) 0.97
Clinical symptoms and IgE responses to common food proteins and inhalants in the first 7 years of life. Clin Allergy (1987) 0.96
Translation of questions: the International Study of Asthma and Allergies in Childhood (ISAAC) experience. Int J Tuberc Lung Dis (2009) 0.96
Effect of maternal avoidance of eggs, cow's milk and fish during lactation upon allergic manifestations in infants. Clin Exp Allergy (1989) 0.96
Sensitizing ability of derivatives of picryl chloride after exposure of mice on the skin and in the lung. Int Arch Allergy Appl Immunol (1983) 0.95
Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine (1995) 0.95